Analysis Article • May 01

Over the last 7 days, the Clinical Research and Equipment industry has dropped 3.4%, driven by AddLife declining 3.2%. Overall the industry is down 17% in 12 months. Looking forward, earnings are forecast to grow by 28% annually.
Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 22 Jun 2026 | SEK 28.9b | SEK 14.6b | -SEK 871,304,353.00 | 33.4x | -33.1x | 2x |
| Wed, 20 May 2026 | SEK 29.3b | SEK 14.6b | -SEK 850,163,077.00 | 36.6x | -34.5x | 2x |
| Fri, 17 Apr 2026 | SEK 30.9b | SEK 14.6b | -SEK 971,664,077.00 | 35.6x | -31.8x | 2.1x |
| Sun, 15 Mar 2026 | SEK 26.9b | SEK 14.6b | -SEK 838,374,077.00 | 32.4x | -32.1x | 1.8x |
| Tue, 10 Feb 2026 | SEK 28.9b | SEK 14.8b | -SEK 578,515,427.00 | 39.1x | -49.9x | 2x |
| Thu, 08 Jan 2026 | SEK 30.9b | SEK 14.9b | -SEK 744,515,427.00 | 48.3x | -41.5x | 2.1x |
| Sat, 06 Dec 2025 | SEK 33.4b | SEK 14.9b | -SEK 744,515,427.00 | 55.6x | -44.9x | 2.3x |
| Mon, 03 Nov 2025 | SEK 38.0b | SEK 14.8b | SEK 117.3m | 56.5x | 323.8x | 2.6x |
| Wed, 01 Oct 2025 | SEK 33.9b | SEK 14.7b | SEK 61.3m | 57x | 553.4x | 2.3x |
| Fri, 29 Aug 2025 | SEK 35.0b | SEK 14.7b | SEK 59.9m | 59.4x | 584.7x | 2.4x |
| Sun, 27 Jul 2025 | SEK 36.7b | SEK 14.8b | SEK 186.0m | 65.8x | 197.2x | 2.5x |
| Tue, 24 Jun 2025 | SEK 44.4b | SEK 16.6b | SEK 405.8m | 69.9x | 109.3x | 2.7x |
| Thu, 22 May 2025 | SEK 45.8b | SEK 16.6b | SEK 415.0m | 45x | 110.4x | 2.8x |
| Sat, 19 Apr 2025 | SEK 36.9b | SEK 16.6b | SEK 609.4m | 39.6x | 60.5x | 2.2x |
| Mon, 17 Mar 2025 | SEK 38.0b | SEK 16.6b | SEK 614.9m | 38.5x | 61.8x | 2.3x |
| Wed, 12 Feb 2025 | SEK 43.8b | SEK 17.0b | -SEK 1,038,511,426.00 | 43.2x | -42.1x | 2.6x |
| Fri, 10 Jan 2025 | SEK 43.5b | SEK 16.7b | -SEK 1,152,911,426.00 | 50.8x | -37.8x | 2.6x |
| Sun, 08 Dec 2024 | SEK 43.4b | SEK 16.7b | -SEK 1,154,323,426.00 | 50.1x | -37.6x | 2.6x |
| Tue, 05 Nov 2024 | SEK 44.1b | SEK 16.8b | -SEK 958,019,827.00 | 50.7x | -46x | 2.6x |
| Thu, 03 Oct 2024 | SEK 47.6b | SEK 16.7b | -SEK 988,175,491.00 | 58.8x | -48.1x | 2.9x |
| Sat, 31 Aug 2024 | SEK 49.5b | SEK 16.7b | -SEK 987,374,492.00 | 62.9x | -50.1x | 3x |
| Mon, 29 Jul 2024 | SEK 49.5b | SEK 16.7b | -SEK 1,128,120,510.00 | 62.6x | -43.8x | 3x |
| Wed, 26 Jun 2024 | SEK 41.2b | SEK 16.3b | -SEK 1,188,686,510.00 | 52.8x | -34.7x | 2.5x |
| Fri, 24 May 2024 | SEK 42.4b | SEK 16.3b | -SEK 1,188,529,510.00 | 61x | -35.7x | 2.6x |
| Sun, 21 Apr 2024 | SEK 36.6b | SEK 16.0b | -SEK 1,122,792,213.00 | 34.3x | -32.6x | 2.3x |
| Tue, 19 Mar 2024 | SEK 38.2b | SEK 16.0b | -SEK 1,123,139,210.00 | 33x | -34x | 2.4x |
| Thu, 15 Feb 2024 | SEK 38.7b | SEK 15.8b | -SEK 1,473,823,683.00 | 58.7x | -26.2x | 2.4x |
| Sat, 13 Jan 2024 | SEK 38.3b | SEK 15.5b | -SEK 1,393,723,683.00 | 47x | -27.5x | 2.5x |
| Mon, 11 Dec 2023 | SEK 36.5b | SEK 15.5b | -SEK 1,393,723,683.00 | 44.2x | -26.2x | 2.4x |
| Wed, 08 Nov 2023 | SEK 30.7b | SEK 15.4b | -SEK 1,256,647,710.00 | 34.2x | -24.5x | 2x |
| Fri, 06 Oct 2023 | SEK 25.7b | SEK 15.1b | -SEK 1,134,516,711.00 | 36.2x | -22.7x | 1.7x |
| Sun, 03 Sep 2023 | SEK 30.6b | SEK 15.1b | -SEK 1,134,263,831.00 | 42.1x | -27x | 2x |
| Tue, 01 Aug 2023 | SEK 32.7b | SEK 15.1b | -SEK 213,871,038.00 | 46.5x | -153.1x | 2.2x |
| Thu, 29 Jun 2023 | SEK 34.8b | SEK 14.6b | -SEK 172,476,038.00 | 36.8x | -201.9x | 2.4x |
-201.9x
How does Swedish Clinical Research and Equipment compare with similar industries?
| SE Market | 0.44% | |
| Healthcare | -2.93% | |
| Life Sciences | -3.38% | |
| Clinical Research and Equipment | -3.38% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BICO BICO Group | SEK 16.56 | 1.5% +SEK 16.9m | -50.1% | PS0.8x | |
| ATANA Attana | SEK 0.005 | 25.0% +SEK 2.6m | -75.0% | PS4.5x | |
| PRO Promimic | SEK 10.60 | 1.0% +SEK 1.9m | -41.4% | PS4x | |
| LEVBIO Level Bio | SEK 0.30 | 3.5% +SEK 684.0k | 7.2% | PS0.6x |